Complications after frame-based stereotactic brain biopsy: a systematic review

Riche, Maximilien; Amelot, Aymeric; Peyre, Matthieu; Laurent, Césari; Carpentier, Alexandre; Mathon, Bertrand

doi:10.1007/s10143-019-01234-w

Cited by 95 publications

(72 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore analysis of brain tissue can have a higher likelihood of finding the causative agent as illustrated in this and a previous report [9]. However, brain biopsy has several limitations: there is risk for bleeding and neurological damage due to the trauma [10,11]. There are also difficulties to access deeper affected areas.…”

Section: Discussionmentioning

confidence: 81%

Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child

Nilsson

Edner

Albert

et al. 2020

Infectious Diseases

View full text Add to dashboard Cite

A child with pre-B acute lymphoblastic leukaemia (ALL) developed fatal encephalitis associated with human coronavirus OC43 (HCoV-OC43). During chemotherapy the child had a persistent HCoV-OC43 respiratory infection and later developed progressive encephalitis. Cerebrospinal fluid was negative for pathogens including HCoV-OC43, but a brain biopsy was HCoV-OC43-positive by metagenomic next-generation sequencing. KEYWORDSCoronavirus encephalitis next generation sequencing brain biopsy ARTICLE HISTORY

show abstract

Section: Discussionmentioning

confidence: 81%

Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child

Nilsson

Edner

Albert

et al. 2020

Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…Pertinently, brain biopsy is an invasive procedure as its complications may be fatal. However, large series of brain biopsies obtained for brain tumor investigations showed that permanent neurological morbidity and mortality frequencies were low, ranging from 0 to 5.6% [39,40] and 0 to 4% [41,42], respectively. Herein, we also reported a low rate of severe (grade 3-4, 1.7%) complications in the setting of neurological diseases of unknown etiology.…”

Section: Discussionmentioning

confidence: 99%

Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety

Mathon

Joncour

Bielle³

et al. 2020

European Journal of Internal Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

“…We recorded the symptomatic complications as well as the asymptomatic hemorrhages that were visible only on a postoperative CT scan. 4,5…”

Section: Study Variables and Outcomesmentioning

confidence: 99%

Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background and Purpose The rationale for performing a second brain biopsy after initial negativity is not well evaluated in the literature. This study was designed to 1) assess the efficacy of a second brain biopsy when the first biopsy was nondiagnostic, 2) identify possible factors associated with an increased diagnostic rate in the second biopsy, and 3) analyze additional morbidity induced by the second biopsy. Methods We performed a retrospective cohort study from 2009 to 2019, during which 1,919 patients underwent a brain biopsy, including 30 who were biopsied twice (1.6%). The specific histological diagnosis rate, diagnosis-associated factors, and complication rate were assessed for the 30 twice-biopsied patients. Results The second biopsy allowed a specific histological diagnosis in 86.7% of the patients who had initially undergone a nondiagnostic brain biopsy [odds ratio (OR)=7.5, 95% confidence interval (CI)=3.0-18.7, p<0.001]. The multivariate analysis showed that only prebiopsy corticosteroid administration (OR=2.6, 95% CI=1.1-6.0, p=0.01) was an important factor in predicting a nondiagnostic biopsy. None of the patients developed a symptomatic complication after the first biopsy, while two (6.0%) patients experienced a transient complication after the second biopsy (p=0.49). Conclusions Performing a second brain biopsy in patients who have an initial nondiagnostic biopsy is effective in most cases. We advocate that a second biopsy be systematically considered in the diagnosis algorithm of these patients after it has been verified that molecular testing cannot help to obtain a diagnosis. Corticosteroid administration can lead to nondiagnostic biopsies and should be avoided when possible during the prebiopsy period.

show abstract

Complications after frame-based stereotactic brain biopsy: a systematic review

Cited by 95 publications

References 37 publications

Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child

Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child

Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety

Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity

Contact Info

Product

Resources

About